Alice Cronin-Golomb

Dr. Alice Cronin-Golomb graduated from the California Institute of Technology in 1984 with a Ph.D. in Psychobiology, after receiving a B.A. in Biology-Psychology from Wesleyan University. She joined Boston University in 1989 and is a faculty member in the Department of Psychological and Brain Sciences, in both the Clinical Program and the Program in Brain, Behavior, and Cognition, as well as the interdisciplinary Center for Systems Neuroscience and Neurophotonics Center. She is director, along with Dr. Michael Lyons, of the Center for Clinical Biopsychology and is director of the Vision and Cognition Laboratory. Dr. Cronin-Golomb’s lab on the Charles River Campus collaborates with faculty from the College of Health and Rehabilitation Sciences: Sargent College and from Biomedical Engineering, and with faculty from the Medical Campus; the VA Boston Healthcare System; and the BU-affiliated Framingham Heart Study, the latter in regard to disease biomarkers. She teaches courses at the undergraduate and graduate level in Neuropsychology.

Dr. Cronin-Golomb’s principal research focus is on the neural correlates of perception, cognition, motor function, mood, sleep, and other aspects of daily function in aging and age-related neurodegenerative disease. Her main methodology is behavioral and includes sensory/cognitive neuroscience, neuropsychological assessment, neuroimaging (functional near infrared spectroscopy), and visual psychophysics. A current emphasis is on the non-motor symptoms of Parkinson’s disease and their interaction with motor symptoms. Her lab engages in basic research and in the development of interventions to enhance the quality of life. Dr. Cronin-Golomb also has a long-standing interest in perception and cognition in Alzheimer’s disease and actively collaborates on projects in this area. Her work and that of her students is supported by the National Institute of Health, the American Parkinson’s Disease Association, the Boston University Alzheimer Disease Center, the Boston University Institute for Health System Innovation & Policy including the Digital Health Initiative, and the Boston University Interdisciplinary Biomedical Research Office Affinity Research Collaborative.